产后出血的管理:如何改善产妇结局?
本文综述产后出血管理在改善产妇结局方面面临的四项挑战:重度产后出血定义不利于早期识别高危产妇;预防子宫切除的手术与放射干预成功率不一;晶体与胶体液复苏可能导致稀释性凝血病;凝血病诊断与纠正仍需深入理解。迄今早期使用氨甲环酸是唯一被证实改善产妇结局的止血干预。
要点
- 当前重度产后出血定义不利于早期识别高危产妇,休克指数和预警系统等临床工具可能有助于早期识别。
- 宫内球囊填塞早期时机可能改善产妇结局,而动脉栓塞早期时机似乎与产妇结局无关。
- 产后出血早期晶体与胶体液复苏不可避免,但可能导致稀释性凝血病。
核心结论
- 产后出血管理的四项挑战涉及重度产后出血定义、预防子宫切除干预的成功率、液体复苏所致稀释性凝血病以及凝血病的诊断与纠正。
- 迄今早期使用氨甲环酸是唯一被证实改善产后出血产妇结局的止血干预。
研究设计与样本
- 本文为综述,讨论产后出血管理面临的至少四项挑战。
主要发现
- 当前重度产后出血定义妨碍早期识别不良结局高风险产妇,调整定义并使用休克指数和预警系统等临床工具可能促进早期识别。
- scarce数据提示宫内球囊填塞早期时机可能改善产妇结局,而动脉栓塞早期时机似乎与产妇结局无关。
- 产后出血早期晶体与胶体液复苏不可避免,但可能导致稀释性凝血病,不同容量清液对稀释性凝血病发生及产妇结局的影响未知。
- 产后出血开始时低血浆纤维蛋白原水平预测进展为重度出血,但标准凝血筛查耗时,床旁凝血检测的临床实用性在产后出血中尚未被证实。
- 迄今早期使用氨甲环酸是唯一被证实改善产后出血产妇结局的止血干预。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Postpartum hemorrhage is the leading cause of maternal mortality and severe morbidity. Despite efforts to improve maternal outcomes, management of postpartum hemorrhage still faces at least four challenges, discussed in this review. First, current definitions for severe postpartum hemorrhage hamper early identification of women with a high risk of adverse outcomes. Adaptations to the definitions and the use of clinical tools such as shock index and early warning systems may facilitate this early identification. Second, surgical and radiological interventions to prevent hysterectomy are not always successful. More knowledge on the influence of patient and bleeding characteristics on the success rates of these interventions is necessary. Scarce data suggest that early timing of intrauterine balloon tamponade may improve maternal outcomes, whereas early timing of arterial embolization seems to be unrelated to maternal outcomes. Third, fluid resuscitation with crystalloids and colloids is unavoidable in the early phases of postpartum hemorrhage but may result in dilutional coagulopathy. Effects of different volumes of clear fluids on the occurrence of dilutional coagulopathy and maternal outcomes is unknown. Fourth, a better understanding of diagnosis and correction of coagulopathy during postpartum hemorrhage is needed. Low plasma fibrinogen levels at the start of postpartum hemorrhage predict progression to severe hemorrhage, but standard coagulation screens are time consuming. A solution may be point-of-care coagulation testing; however, clinical usefulness during postpartum hemorrhage has not been demonstrated. To date, early administration of tranexamic acid is the only hemostatic intervention that was proven to improve outcomes in women with postpartum hemorrhage.
引用
- Henriquez DDCA, Bloemenkamp KWM, van der Bom JG, et al. Management of postpartum hemorrhage: how to improve maternal outcomes? J Thromb Haemost. 2018. PMID: 29883040. doi:10.1111/jth.14200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。